| First Author | Taifour T | Year | 2023 |
| Journal | Immunity | Volume | 56 |
| Issue | 12 | Pages | 2755-2772.e8 |
| PubMed ID | 38039967 | Mgi Jnum | J:343706 |
| Mgi Id | MGI:7568727 | Doi | 10.1016/j.immuni.2023.11.002 |
| Citation | Taifour T, et al. (2023) The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity 56(12):2755-2772.e8 |
| abstractText | In triple-negative breast cancer (TNBC), stromal restriction of CD8(+) T cells associates with poor clinical outcomes and lack of responsiveness to immune-checkpoint blockade (ICB). To identify mediators of T cell stromal restriction, we profiled murine breast tumors lacking the transcription factor Stat3, which is commonly hyperactive in breast cancers and promotes an immunosuppressive tumor microenvironment. Expression of the cytokine Chi3l1 was decreased in Stat3(-/-) tumors. CHI3L1 expression was elevated in human TNBCs and other solid tumors exhibiting T cell stromal restriction. Chi3l1 ablation in the polyoma virus middle T (PyMT) breast cancer model generated an anti-tumor immune response and delayed mammary tumor onset. These effects were associated with increased T cell tumor infiltration and improved response to ICB. Mechanistically, Chi3l1 promoted neutrophil recruitment and neutrophil extracellular trap formation, which blocked T cell infiltration. Our findings provide insight into the mechanism underlying stromal restriction of CD8(+) T cells and suggest that targeting Chi3l1 may promote anti-tumor immunity in various tumor types. |
